Equities researchers at Zacks Research upped their Q3 2025 earnings per share estimates for shares of Vertex Pharmaceuticals ...

This was the stock's fourth consecutive day of gains.

JMP Securities raised the firm’s price target on Rhythm Pharmaceuticals (RYTM) to $75 from $64 and keeps an Outperform rating on the shares as part of a broader note on Biotechnology.

Greek yogurt, the creamy treat with its thick consistency and distinctive tartness, has long been a favorite across the world for its taste. Now, researchers say, Greek yogurt may also be beneficial ...